Press Releases Archives - Page 11 of 103 - Lupin

BSE 2307.55 NSE 2307.90

indian flag icon

India

USA

great-britain flag icon

UK

south-africa flag icon

South Africa

australia flag icon

Australia

philippines flag icon

Philippines

germany flag icon

Germany

netherlands flag icon

Netherlands

mexico flag icon

Mexico

brazil flag icon

Brazil

canada flag icon

Canada

Switzerland flag icon

Switzerland

BSE 2307.55 NSE 2307.90

Lupin Receives Tentative Approval from U.S. FDA for Raltegravir Tablets, USP

November 8, 2024

Lupin Q2 FY2025 Results

November 7, 2024

Lupin to focus on the development of inhalers with near-zero global warming potential propellants

October 28, 2024

Lupin Appoints Claus Jepsen as President, Global Specialty

October 21, 2024

Lupin Launches First Generic of Pred Forte® in the United States

October 15, 2024

Lupin Launches Aptivate Achi Bhookh Fest in Mumbai and Suburbs

October 14, 2024

Lupin Acquires Nine Brands of Medical Nutritional Institute in South Africa

October 4, 2024

Lupin and Scope Sign a Distribution Agreement for the Commercialization of Optase® Range of Products in Mexico

September 30, 2024

Lupin Signs Distribution Agreement with Celnova for Orphan Drug NaMuscla®

September 27, 2024

Lupin Receives Approval from U.S. FDA for Bumetanide Injection, USP

September 18, 2024

1 2 … 10 11 12 … 102 103

Search

Hit enter to search or ESC to close